This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Mansson, P.-E. Articles by McKeehan, W. L. Search for Related Content PubMed PubMed Citation Articles by Mansson, P.-E. Articles by McKeehan, W. L.

Heparin-binding Growth Factor Gene Expression and Receptor Characteristics in Normal Rat Prostate and Two Transplantable Rat Prostate Tumors¹

W. Alton Jones Cell Science Center, Inc., Lake Placid, New York 12946

Heparin-binding polypeptide growth factors (HBGF) are essential mitogens for isolated prostate cells. HBGF type one (HBGF-1) mRNA was expressed specifically in the epithelial cells of prostates from normal 6- to 8-week-old rats. Expression declined significantly at 14 weeks and was undetectable in 35-week-old animals. Slow-growing, androgen-responsive, nonmetastatic Dunning R3327PAP tumors, which are composed of a well-defined epithelium and stroma, expressed HBGF-1 mRNA constitutively in specifically the mesenchymal cells. A rapidgrowing, androgen-independent, metastatic variant (Dunning R3327AT-3), which was composed of a single clonogenic cell type, expressed both HBGF-1 and HBGF type two (HBGF-2) mRNA. HBGF activity in the extracts of normal and tumor tissues correlated with mRNA levels. Epithelial cells from the R3327PAP tumor and the single cell type that composed the R3327AT-3 tumor exhibited alterations in HBGF receptor characteristics that correlated with increased sensitivity to mitogenic effects of HBGF. The results suggest that alterations in HBGF gene expression in both prostate epithelial and mesenchymal cells and in properties of the receptor in specifically epithelial cells may contribute to differential growth rates and malignancy of different prostatic tumors.

¹ This work was supported by National Cancer Institute Grant CA37589.

² To whom requests for reprints should be addressed, at W. Alton Jones Cell Science Center, Inc., 10 Old Barn Road, Lake Placid, NY 12946.

Received 7/ 6/88. Revised 10/ 7/88. Revised 1/18/89. Accepted 1/30/89.

This article has been cited by other articles:

				J. C. O'Connor, M. C. Farach-Carson, C. J. Schneider, and D. D. Carson Coculture with Prostate Cancer Cells Alters Endoglin Expression and Attenuates Transforming Growth Factor-{beta} Signaling in Reactive Bone Marrow Stromal Cells Mol. Cancer Res., June 1, 2007; 5(6): 585 - 603. [Abstract] [Full Text] [PDF]

				C. Jin, F. Wang, X. Wu, C. Yu, Y. Luo, and W. L. McKeehan Directionally Specific Paracrine Communication Mediated by Epithelial FGF9 to Stromal FGFR3 in Two-Compartment Premalignant Prostate Tumors Cancer Res., July 1, 2004; 64(13): 4555 - 4562. [Abstract] [Full Text] [PDF]

				X. Wu, C. Jin, F. Wang, C. Yu, and W. L. McKeehan Stromal Cell Heterogeneity in Fibroblast Growth Factor-mediated Stromal-Epithelial Cell Cross-Talk in Premalignant Prostate Tumors Cancer Res., August 15, 2003; 63(16): 4936 - 4944. [Abstract] [Full Text] [PDF]

				X. Wu, M. Kan, F. Wang, C. Jin, C. Yu, and W. L. McKeehan A Rare Premalignant Prostate Tumor Epithelial Cell Syndecan-1 Forms a Fibroblast Growth Factor-binding Complex with Progression-promoting Ectopic Fibroblast Growth Factor Receptor 1 Cancer Res., July 1, 2001; 61(13): 5295 - 5302. [Abstract] [Full Text] [PDF]

				M. A. Sortino, F. Condorelli, C. Vancheri, A. Chiarenza, R. Bernardini, U. Consoli, and P. L. Canonico Mitogenic Effect of Nerve Growth Factor (NGF) in LNCaP Prostate Adenocarcinoma Cells: Role of the High- and Low-Affinity NGF Receptors Mol. Endocrinol., January 1, 2000; 14(1): 124 - 136. [Abstract] [Full Text]

				W. Lu, Y. Luo, M. Kan, and W. L. McKeehan Fibroblast Growth Factor-10. A SECOND CANDIDATE STROMAL TO EPITHELIAL CELL ANDROMEDIN IN PROSTATE J. Biol. Chem., April 30, 1999; 274(18): 12827 - 12834. [Abstract] [Full Text] [PDF]

				P. J. Russell, S. Bennett, and P. Stricker Growth factor involvement in progression of prostate cancer Clin. Chem., April 1, 1998; 44(4): 705 - 723. [Abstract] [Full Text] [PDF]

				T. A. Guise and G. R. Mundy Cancer and Bone Endocr. Rev., February 1, 1998; 19(1): 18 - 54. [Abstract] [Full Text]

				F. Wang, M. Kan, G. Yan, J. Xu, and W. L. McKeehan Alternately Spliced NH[IMAGE]-terminal Immunoglobulin-like Loop I in the Ectodomain of the Fibroblast Growth Factor (FGF) Receptor 1 Lowers Affinity for both Heparin and FGF-1 J. Biol. Chem., April 28, 1995; 270(17): 10231 - 10235. [Abstract] [Full Text] [PDF]